Cosmos Health Inc. - SIC # 7352 - MEDICAL EQUIPMENT RENTAL AND LEASING

Ticker Exchange SIC # Website Latest Ticker
COSM Nasdaq 7352 www.cosmoshealthinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cosmos Health Inc.

Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - Sep 15th, 2026 8:30 am
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - Sep 14th, 2026 1:59 pm
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - Sep 11th, 2026 9:10 am
COSM Again Expands its Market and Accelerates its Growth - Sep 10th, 2026 6:11 am
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - Sep 9th, 2026 7:30 am
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions - Aug 28th, 2026 7:30 am
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories - Aug 24th, 2026 1:40 pm
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term - Aug 20th, 2026 7:30 am
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway - Aug 19th, 2026 7:00 am
COSM Produces Stellar Quarter - Aug 19th, 2026 5:44 am
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels - Jul 27th, 2026 11:05 am
COSM Marking Huge Growth and Buying Back Shares - Jul 24th, 2026 5:06 am
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units - Jul 20th, 2026 1:46 pm
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases - Jul 17th, 2026 12:55 pm
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases - Jul 16th, 2026 11:15 am
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases - Jul 15th, 2026 12:15 pm
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases - Jul 14th, 2026 12:40 pm
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases - Jul 13th, 2026 1:00 pm
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece - Jul 13th, 2026 11:00 am
Cosmos Health Launches Subscription Model - Jul 10th, 2026 8:55 am